These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 35240292)

  • 1. Nanobodies as molecular imaging probes.
    Barakat S; Berksöz M; Zahedimaram P; Piepoli S; Erman B
    Free Radic Biol Med; 2022 Mar; 182():260-275. PubMed ID: 35240292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NANOBODIES®: A Review of Diagnostic and Therapeutic Applications.
    Jin BK; Odongo S; Radwanska M; Magez S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanobodies as efficient drug-carriers: Progress and trends in chemotherapy.
    Panikar SS; Banu N; Haramati J; Del Toro-Arreola S; Riera Leal A; Salas P
    J Control Release; 2021 Jun; 334():389-412. PubMed ID: 33964364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of Nanobodies.
    Muyldermans S
    Annu Rev Anim Biosci; 2021 Feb; 9():401-421. PubMed ID: 33233943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping cytoskeletal protein function in cells by means of nanobodies.
    Van Audenhove I; Van Impe K; Ruano-Gallego D; De Clercq S; De Muynck K; Vanloo B; Verstraete H; Fernández LÁ; Gettemans J
    Cytoskeleton (Hoboken); 2013 Oct; 70(10):604-22. PubMed ID: 23818458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A guide to: generation and design of nanobodies.
    Muyldermans S
    FEBS J; 2021 Apr; 288(7):2084-2102. PubMed ID: 32780549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.
    Romao E; Morales-Yanez F; Hu Y; Crauwels M; De Pauw P; Hassanzadeh GG; Devoogdt N; Ackaert C; Vincke C; Muyldermans S
    Curr Pharm Des; 2016; 22(43):6500-6518. PubMed ID: 27669966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanobodies®: proficient tools in diagnostics.
    Huang L; Muyldermans S; Saerens D
    Expert Rev Mol Diagn; 2010 Sep; 10(6):777-85. PubMed ID: 20843201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NanoBERTa-ASP: predicting nanobody paratope based on a pretrained RoBERTa model.
    Li S; Meng X; Li R; Huang B; Wang X
    BMC Bioinformatics; 2024 Mar; 25(1):122. PubMed ID: 38515052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affimers and nanobodies as molecular probes and their applications in imaging.
    Cordell P; Carrington G; Curd A; Parker F; Tomlinson D; Peckham M
    J Cell Sci; 2022 Jul; 135(14):. PubMed ID: 35848463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and Screening of Antigen-Specific Nanobodies from Mammalian Cells Expressing the BCR Repertoire Library Using Droplet-Based Microfluidics.
    Lyu M; Shi X; Liu X; Liu Y; Zhu X; Liao L; Zhao H; Sun N; Wang S; Chen L; Fan L; Xu Q; Zhu Q; Gao K; Chen H; Zhu Y; Li Z; Guo W; Zheng Y; Gu Y; Liu L; Wang M; Liu Y
    Anal Chem; 2022 Jun; 94(22):7970-7980. PubMed ID: 35604850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanobodies as Versatile Tool for Multiscale Imaging Modalities.
    Erreni M; Schorn T; D'Autilia F; Doni A
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33353213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use.
    Lecocq Q; Zeven K; De Vlaeminck Y; Martens S; Massa S; Goyvaerts C; Raes G; Keyaerts M; Breckpot K; Devoogdt N
    Biomolecules; 2019 Sep; 9(10):. PubMed ID: 31569553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanobodies derived from Camelids represent versatile biomolecules for biomedical applications.
    Yu X; Xu Q; Wu Y; Jiang H; Wei W; Zulipikaer A; Guo Y; Jirimutu ; Chen J
    Biomater Sci; 2020 Jul; 8(13):3559-3573. PubMed ID: 32490444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanobodies in cancer.
    Verhaar ER; Woodham AW; Ploegh HL
    Semin Immunol; 2021 Feb; 52():101425. PubMed ID: 33272897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering nanobodies for next-generation molecular imaging.
    Yang E; Liu Q; Huang G; Liu J; Wei W
    Drug Discov Today; 2022 Jun; 27(6):1622-1638. PubMed ID: 35331925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor.
    Kazemi-Lomedasht F; Behdani M; Habibi-Anbouhi M; Shahbazzadeh D
    Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):167-71. PubMed ID: 27167350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanobodies: The "Magic Bullets" in therapeutics, drug delivery and diagnostics.
    Mir MA; Mehraj U; Sheikh BA; Hamdani SS
    Hum Antibodies; 2020; 28(1):29-51. PubMed ID: 31322555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in nanobody and its application in diagnosis].
    Kong Q; Yao Y; Chen R; Lu S
    Sheng Wu Gong Cheng Xue Bao; 2014 Sep; 30(9):1351-61. PubMed ID: 25720150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanobodies: The Future of Antibody-Based Immune Therapeutics.
    Bathula NV; Bommadevara H; Hayes JM
    Cancer Biother Radiopharm; 2021 Mar; 36(2):109-122. PubMed ID: 32936001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.